| Insideraktier | 7 464 864 shares |
Insider Sentiment Score
Insider sentiment score hittar de företag som köps av foretagsinsynspersoner.
Det är resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av insiderackumulation. Poängmodellen använder en kombination av nettoantalet insiders som köpt de föregående 90 dagarna, det totala antalet aktier som köpts i procent av aktiekapitalet och det totala antalet aktier som ägs av insiders. Siffran sträcker sig från 0 till 100, med högre siffror som indikerar en högre nivå av ackumulering för sina kamrater, och 50 är genomsnittet.
Uppdateringsfrekvens: Dagligen
Se Insiders Top Picks, som ger en lista över företag med högsta insiderackumulation.
Office Sentiment Score
Officersentiment Score hittar företag som köps av Corporate Officers.
Per definition Corporate Officers är Corporate Insiders, men till skillnad från vissa av de andra Insiders (10 % aktieägare och styrelseledamöter), arbetar ämbetsmän för företaget dagligen och de använder sina egna pengar när de handlar . (10 % aktieägare och styrelseledamöter är ofta fondförvaltare som förvaltar andras pengar.) Som sådan är insideraffärer som görs av tjänstemän mycket mer betydelsefulla och bör behandlas på lämpligt sätt.
Liksom Insider Sentiment Score är Officer Sentiment Score resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av officersackumulering.
Uppdateringsfrekvens: Dagligen
Se insiderns bästa val, vilket ger en lista över företag med högsta insider sentiment.
Viktiga insidernyckeltal
Denna kort visar hur företaget rankas längs olika insidernyckeltal. Procenttilrankningen visar hur detta företag jämförs med andra företag på USA-marknaden. Högre rankingar indikerar bättre situationer.
Till exempel anses det allmänt att insiderköp är en positiv indikator, så företag med mer insiderköp skulle rankas högre än företag med mindre insiderköp (eller til och med insiderförsäljning).
Nettoantalet insiders som köper (rankning)
N/A
Nettoantalet insiders som köper är den totala mängden insiders som säljer minus det totala antalet insiders som säljer under de senaste 90 dagarna. Percentilrankningen visas här (intervall från 0 till 100%).
Procent av flytande köpta av insiders (ranking)
N/A
Procentandelen av aktier köpta av insiders är det totala antalet aktier som köpts av insiders minus det totala antalet aktier som sålts av insiders under de senaste 90 dagarna, dividerat med det totala antalet aktier och multiplicerat med 100.
Insiderhandelsdiagram
Sierra Oncology Inc insideraffärer visas i följande diagram. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. I allmänhet är det i allmänhet olagligt för insiders att göra affärer i sina företag baserat på väsentlig, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4.
Insiderlista och lönsamhetsstatistik
Den här tabellen visar listan över kända insiders och genereras automatiskt från anmälningar som avslöjas till SEC. Förutom namnen, den senaste titeln och direktören, tjänstemannen eller ägarbeteckningen på 10 %, tillhandahåller vi de senaste avslöjade innehaven. Dessutom, när det är möjligt tillhandahåller vi insiderns historiska handelsresultat. Det historiska handelsresultatet är ett vägt genomsnitt av resultatet för faktiska köptransaktioner på den öppna marknaden som insidern gjort. För mer information om hur detta beräknas, titta på detta YouTube-webinarium.
See our leaderboard of most profitable insider traders.
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|
Report errors via our new Insider Auditing Tool
Track Records av insiderköp - Kortsiktig vinstanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i SRRA / Sierra Oncology Inc. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste köpen på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Track Records av insiderförsäljning - Kortsiktig förlustanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i SRRA / Sierra Oncology Inc. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste försäljningarna på öppna marknaden som inte var en del av en automatisk handelsplan.
| Handelsdatum | Insider | Rapporterade aktier |
Rapporterat pris |
Justerade aktier |
Justerat pris |
Kostnadsbasis | Dagar til Min |
Pris vid Min |
Maximal förlust undvikits ($) |
Maximal förlust undvikits ($) |
|---|---|---|---|---|---|---|---|
| Det finns inga kända oplanerade öppna marknadstransaktioner för denna insynsperson |
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Transaktionshistorik
Klicka på länkikonen för att se hela transaktionshistoriken. Transaktioner som rapporteras som en del av en automatisk handelsplan 10b5-1 kommer att ha ett X i kolumnen markerad 10b-5.
| Fil datum |
Handel datum |
Schema | Insider | Ticker | Värdepappertitel | Kod | Direkta | Utövningspris | Enhet pris |
Enheter ändrad |
Värde ändrad (1K) |
Kvarvarande Optioner |
Kvarvarande Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-07-01 | 2022-07-01 | 4 | Vivo Opportunity, LLC By: Vivo Capital Fund IX, L.P. | SRRA | Common Stock | I | 55,0000 | −431 947 | −23 757 | 0 | ||||
| 2022-07-01 | 2022-07-01 | 4 | Vivo Opportunity, LLC By: Vivo Opportunity Fund Holdings, L.P. | SRRA | Common Stock | I | 55,0000 | −2 735 853 | −150 472 | 0 | ||||
| 2022-07-01 | 2022-07-01 | 4 | Vivo Opportunity, LLC By: Vivo Ventures Fund VII, L.P. and Vivo Ventures VII Affiliates Fund, L.P. | SRRA | Common Stock | I | 55,0000 | −161 712 | −8 894 | 0 | ||||
| 2022-07-01 | 2022-07-01 | 4 | ORBIMED ADVISORS LLC See footnotes | SRRA | Common Stock | I | 55,0000 | −226 704 | −12 469 | 0 | ||||
| 2022-07-01 | 2022-07-01 | 4 | ORBIMED ADVISORS LLC See footnotes | SRRA | Common Stock | I | 55,0000 | −226 704 | −12 469 | 0 | ||||
| 2022-07-01 | 2022-07-01 | 4 | ORBIMED ADVISORS LLC See footnotes | SRRA | Common Stock | I | 55,0000 | −1 511 362 | −83 125 | 0 | ||||
| 2022-07-01 | 2022-07-01 | 4 | Ashiya Mona See footnotes | SRRA | Common Stock | I | 55,0000 | −226 704 | −12 469 | 0 | ||||
| 2022-07-01 | 2022-07-01 | 4 | Ashiya Mona See footnotes | SRRA | Common Stock | I | 55,0000 | −226 704 | −12 469 | 0 | ||||
| 2022-07-01 | 2022-07-01 | 4 | Ashiya Mona See footnotes | SRRA | Common Stock | I | 55,0000 | −1 511 362 | −83 125 | 0 | ||||
| 2022-07-01 | 2022-07-01 | 4 | Aggarwal Gaurav By: Vivo Opportunity Fund Holdings, L.P. | SRRA | Common Stock | I | 55,0000 | −2 735 853 | −150 472 | 0 | ||||
| 2022-07-01 | 2022-07-01 | 4 | Klencke Barbara By spouse | SRRA | Common Stock | I | 55,0000 | −5 000 | −275 | 0 | ||||
| 2022-07-01 | 2022-07-01 | 4 | Klencke Barbara | SRRA | Common Stock | D | 55,0000 | −10 000 | −550 | 0 | ||||
| 2022-07-01 | 2022-07-01 | 4 | Sinclair Andrew See footnotes | SRRA | Common Stock, $0.001 par value | I | 55,0000 | −1 314 127 | −72 277 | 0 | ||||
| 2022-07-01 | 2022-07-01 | 4 | Allen Andrew R | SRRA | Common Stock | D | 55,0000 | −1 650 | −91 | 0 | ||||
| 2022-07-01 | 2022-07-01 | 4 | Collard Craig A | SRRA | Common Stock | D | 55,0000 | −13 500 | −742 | 0 | ||||
| 2022-07-01 | 2022-07-01 | 4 | DILLY STEPHEN GEORGE | SRRA | Common Stock | D | 55,0000 | −5 000 | −275 | 0 | ||||
| 2022-04-29 | 2022-04-27 | 4 | Longitude Capital Partners III, LLC | SRRA | Common Stock | I | 840 | 8 015 | ||||||
| 2022-04-29 | 2022-04-27 | 4 | Longitude Capital Partners III, LLC | SRRA | Common Stock | I | 252 | 2 404 | ||||||
| 2022-04-29 | 2022-04-27 | 4 | Longitude Capital Partners III, LLC | SRRA | Common Stock | I | 588 | 5 611 | ||||||
| 2022-04-29 | 2022-04-27 | 4 | Longitude Capital Partners III, LLC | SRRA | Common Stock | I | 7 175 | 7 175 | ||||||
| 2022-04-29 | 2022-04-27 | 4 | Longitude Capital Partners III, LLC | SRRA | Common Stock | I | 2 152 | 2 152 | ||||||
| 2022-04-29 | 2022-04-27 | 4 | Longitude Capital Partners III, LLC | SRRA | Common Stock | I | 5 023 | 5 023 | ||||||
| 2022-04-29 | 2022-04-27 | 4 | Longitude Capital Partners III, LLC | SRRA | Common Stock | I | −1 964 771 | 0 | ||||||
| 2022-04-29 | 2022-04-27 | 4 | Longitude Capital Partners III, LLC | SRRA | Common Stock | I | −175 000 | 0 | ||||||
| 2022-04-07 | 2022-04-06 | 4 | Turner William D. | SRRA | Stock Option (Right to Buy) | D | 12,05 | 6 347 | 0 | |||||
| 2022-04-07 | 2022-04-06 | 4 | Turner William D. | SRRA | Common Stock | D | 37,2474 | −6 347 | −236 | 0 | ||||
| 2022-04-07 | 2022-04-06 | 4 | Turner William D. | SRRA | Common Stock | D | 12,0500 | 6 347 | 76 | 6 347 | ||||
| 2022-04-07 | 2022-04-05 | 4 | Turner William D. | SRRA | Stock Option (Right to Buy) | D | 12,05 | 100 | 0 | |||||
| 2022-04-07 | 2022-04-05 | 4 | Turner William D. | SRRA | Common Stock | D | 37,0900 | −100 | −4 | 0 | ||||
| 2022-04-07 | 2022-04-05 | 4 | Turner William D. | SRRA | Common Stock | D | 12,0500 | 100 | 1 | 100 | ||||
| 2022-04-04 | 2022-04-04 | 4 | Thomson Mary Christina | SRRA | Stock Option (Right to Buy) | D | 13,04 | 2 000 | 0 | |||||
| 2022-04-04 | 2022-04-04 | 4 | Thomson Mary Christina | SRRA | Common Stock | D | 35,1384 | −2 000 | −70 | 0 | ||||
| 2022-04-04 | 2022-04-04 | 4 | Thomson Mary Christina | SRRA | Common Stock | D | 13,0400 | 2 000 | 26 | 2 000 | ||||
| 2022-03-22 | 2022-03-18 | 4 | Turner William D. | SRRA | Stock Option (Right to Buy) | D | 12,05 | 100 | 0 | |||||
| 2022-03-22 | 2022-03-18 | 4 | Turner William D. | SRRA | Common Stock | D | 37,0500 | −100 | −4 | 0 | ||||
| 2022-03-22 | 2022-03-18 | 4 | Turner William D. | SRRA | Common Stock | D | 12,0500 | 100 | 1 | 100 | ||||
| 2022-03-17 | 2022-03-17 | 4 | Turner William D. | SRRA | Stock Option (Right to Buy) | D | 12,05 | 3 453 | 0 | |||||
| 2022-03-17 | 2022-03-17 | 4 | Turner William D. | SRRA | Common Stock | D | 37,0558 | −3 453 | −128 | 0 | ||||
| 2022-03-17 | 2022-03-17 | 4 | Turner William D. | SRRA | Common Stock | D | 12,0500 | 3 453 | 42 | 3 453 | ||||
| 2022-03-14 | 2022-03-14 | 4 | DILLY STEPHEN GEORGE | SRRA | Stock Option (Right to Buy) | D | 31,54 | 165 000 | 165 000 | |||||
| 2022-03-14 | 2022-03-14 | 4 | Jagpal Sukhi | SRRA | Stock Option (Right to Buy) | D | 31,54 | 50 000 | 50 000 | |||||
| 2022-03-14 | 2022-03-14 | 4 | Klencke Barbara | SRRA | Stock Option (Right to Buy) | D | 31,54 | 50 000 | 50 000 | |||||
| 2022-03-14 | 2022-03-14 | 4 | Norrett Kevin | SRRA | Stock Option (Right to Buy) | D | 31,54 | 35 000 | 35 000 | |||||
| 2022-03-14 | 2022-03-14 | 4 | Turner William D. | SRRA | Stock Option (Right to Buy) | D | 31,54 | 35 000 | 35 000 | |||||
| 2022-03-14 | 2022-03-14 | 4 | Thomson Mary Christina | SRRA | Stock Option (Right to Buy) | D | 31,54 | 35 000 | 35 000 | |||||
| 2022-03-04 | 2022-03-04 | 4 | Thomson Mary Christina | SRRA | Stock Option (Right to Buy) | D | 13,04 | 2 000 | 0 | |||||
| 2022-03-04 | 2022-03-04 | 4 | Thomson Mary Christina | SRRA | Common Stock | D | 30,5981 | −2 000 | −61 | 0 | ||||
| 2022-03-04 | 2022-03-04 | 4 | Thomson Mary Christina | SRRA | Common Stock | D | 13,0400 | 2 000 | 26 | 2 000 | ||||
| 2022-02-08 | 2022-02-07 | 4 | Turner William D. | SRRA | Stock Option (Right to Buy) | D | 12,05 | 10 000 | 0 | |||||
| 2022-02-08 | 2022-02-07 | 4 | Turner William D. | SRRA | Common Stock | D | 32,3225 | −10 000 | −323 | 0 | ||||
| 2022-02-08 | 2022-02-07 | 4 | Turner William D. | SRRA | Common Stock | D | 12,0500 | 10 000 | 120 | 10 000 | ||||
| 2022-02-04 | 2022-02-04 | 4 | Thomson Mary Christina | SRRA | Stock Option (Right to Buy) | D | 13,04 | 2 000 | 0 | |||||
| 2022-02-04 | 2022-02-04 | 4 | Thomson Mary Christina | SRRA | Common Stock | D | 29,7800 | −2 000 | −60 | 0 | ||||
| 2022-02-04 | 2022-02-04 | 4 | Thomson Mary Christina | SRRA | Common Stock | D | 13,0400 | 2 000 | 26 | 2 000 | ||||
| 2022-02-02 | 2022-02-02 | 4 | Longitude Capital Partners III, LLC | SRRA | Common Stock | I | 27,0000 | 175 000 | 4 725 | 175 000 | ||||
| 2022-02-02 | 2022-02-02 | 4 | Richardson Joshua | SRRA | Common Stock | I | 27,0000 | 175 000 | 4 725 | 175 000 | ||||
| 2022-02-02 | 3 | Longitude Prime Fund, L.P. | SRRA | Common Stock | I | 175 000 | ||||||||
| 2022-02-01 | 2022-01-31 | 4 | Sinclair Andrew See footnotes | SRRA | Common Stock, $0.001 par value | I | 27,0000 | 150 000 | 4 050 | 1 314 127 | ||||
| 2022-02-01 | 2022-01-28 | 4 | Sinclair Andrew See footnotes | SRRA | Series B Warrants (right to buy) | I | 13,20 | −287 471 | 0 | |||||
| 2022-02-01 | 2022-01-28 | 4 | Sinclair Andrew See footnotes | SRRA | Common Stock, $0.001 par value | I | 13,2000 | 287 471 | 3 795 | 1 164 127 | ||||
| 2022-02-01 | 2022-01-31 | 4 | Abingworth LLP | SRRA | Common Stock, $0.001 par value | I | 27,0000 | 150 000 | 4 050 | 1 314 127 | ||||
| 2022-02-01 | 2022-01-28 | 4 | Abingworth LLP | SRRA | Series B Warrants (right to buy) | I | 13,20 | −287 471 | 0 | |||||
| 2022-02-01 | 2022-01-28 | 4 | Abingworth LLP | SRRA | Common Stock, $0.001 par value | I | 13,2000 | 287 471 | 3 795 | 1 164 127 | ||||
| 2022-01-31 | 2022-01-31 | 4 | Vivo Opportunity, LLC By Vivo Opportunity Fund, L.P. | SRRA | Common Stock | I | 27,0000 | 800 000 | 21 600 | 2 735 853 | ||||
| 2022-01-31 | 2022-01-31 | 4 | Aggarwal Gaurav By Vivo Opportunity Fund, L.P. | SRRA | Common Stock | I | 27,0000 | 800 000 | 21 600 | 2 735 853 | ||||
| 2022-01-28 | 2022-01-26 | 4 | Ashiya Mona See footnotes | SRRA | Series B Warrants | I | 13,20 | −56 244 | 0 | |||||
| 2022-01-28 | 2022-01-26 | 4 | Ashiya Mona See footnotes | SRRA | Series B Warrants | I | 13,20 | −56 244 | 0 | |||||
| 2022-01-28 | 2022-01-26 | 4 | Ashiya Mona See footnotes | SRRA | Series B Warrants | I | 13,20 | −374 962 | 0 | |||||
| 2022-01-28 | 2022-01-26 | 4 | Ashiya Mona See footnotes (4), | SRRA | Common Stock | I | 13,2000 | 56 244 | 742 | 226 704 | ||||
| 2022-01-28 | 2022-01-26 | 4 | Ashiya Mona See footnotes | SRRA | Common Stock | I | 13,2000 | 56 244 | 742 | 226 704 | ||||
| 2022-01-28 | 2022-01-26 | 4 | Ashiya Mona See footnotes (4), | SRRA | Common Stock | I | 13,2000 | 374 962 | 4 949 | 1 511 362 | ||||
| 2022-01-28 | 2022-01-26 | 4 | ORBIMED ADVISORS LLC | SRRA | Series B Warrants | I | 13,20 | −56 244 | 0 | |||||
| 2022-01-28 | 2022-01-26 | 4 | ORBIMED ADVISORS LLC | SRRA | Series B Warrants | I | 13,20 | −56 244 | 0 | |||||
| 2022-01-28 | 2022-01-26 | 4 | ORBIMED ADVISORS LLC | SRRA | Series B Warrants | I | 13,20 | −374 962 | 0 | |||||
| 2022-01-28 | 2022-01-26 | 4 | ORBIMED ADVISORS LLC | SRRA | Common Stock | I | 13,2000 | 56 244 | 742 | 226 704 | ||||
| 2022-01-28 | 2022-01-26 | 4 | ORBIMED ADVISORS LLC See footnote (4), | SRRA | Common Stock | I | 13,2000 | 56 244 | 742 | 226 704 | ||||
| 2022-01-28 | 2022-01-26 | 4 | ORBIMED ADVISORS LLC See footnote (4), | SRRA | Common Stock | I | 13,2000 | 374 962 | 4 949 | 1 511 362 | ||||
| 2022-01-28 | 2022-01-26 | 4 | Vivo Opportunity, LLC By: Vivo Capital Fund IX, L.P. | SRRA | Series B Warrant (Right to Purchase ) | I | 13,20 | 13,2000 | −324 740 | −4 287 | 0 | |||
| 2022-01-28 | 2022-01-26 | 4 | Vivo Opportunity, LLC By: Vivo Opportunity Fund, L.P. | SRRA | Series B Warrant (Right to Purchase ) | I | 13,20 | 13,2000 | −1 455 384 | −19 211 | 0 | |||
| 2022-01-28 | 2022-01-26 | 4 | Vivo Opportunity, LLC By: Vivo Ventures Fund VII, L.P. and Vivo Ventures VII Affiliates Fund, L.P. | SRRA | Series B Warrant (Right to Purchase ) | I | 13,20 | 13,2000 | −75 749 | −1 000 | 0 | |||
| 2022-01-28 | 2022-01-26 | 4 | Vivo Opportunity, LLC By: Vivo Capital Fund IX, L.P. | SRRA | Common Stock | I | 13,2000 | 107 164 | 1 415 | 431 947 | ||||
| 2022-01-28 | 2022-01-26 | 4 | Vivo Opportunity, LLC By: Vivo Opportunity Fund, L.P. | SRRA | Common Stock | I | 13,2000 | 480 277 | 6 340 | 1 935 853 | ||||
| 2022-01-28 | 2022-01-26 | 4 | Vivo Opportunity, LLC By: Vivo Ventures Fund VII, L.P. and Vivo Ventures VII Affiliates Fund, L.P. | SRRA | Common Stock | I | 13,2000 | 24 996 | 330 | 161 712 | ||||
| 2022-01-28 | 2022-01-26 | 4 | Aggarwal Gaurav By Vivo Opportunity Fund, L.P. | SRRA | Series B Warrant (Right to Purchase) | I | 13,20 | 13,2000 | −1 455 384 | −19 211 | 0 | |||
| 2022-01-28 | 2022-01-26 | 4 | Aggarwal Gaurav By Vivo Opportunity Fund, L.P. | SRRA | Common Stock | I | 13,2000 | 480 277 | 6 340 | 1 935 853 | ||||
| 2022-01-28 | 2022-01-28 | 4 | Klencke Barbara | SRRA | Stock Option (Right to Buy) | D | 12,15 | 12 250 | 12 250 | |||||
| 2022-01-28 | 2022-01-28 | 4 | Kowalski Mark | SRRA | Stock Option (Right to Buy) | D | 12,15 | 12 250 | 12 250 | |||||
| 2022-01-28 | 2022-01-28 | 4 | Norrett Kevin | SRRA | Stock Option (Right to Buy) | D | 12,15 | 12 250 | 12 250 | |||||
| 2022-01-28 | 2022-01-28 | 4 | DILLY STEPHEN GEORGE | SRRA | Stock Option (Right to Buy) | D | 12,15 | 65 000 | 65 000 | |||||
| 2022-01-28 | 2022-01-28 | 4 | Jagpal Sukhi | SRRA | Stock Option (Right to Buy) | D | 12,15 | 12 250 | 12 250 | |||||
| 2022-01-28 | 2022-01-28 | 4 | Thomson Mary Christina | SRRA | Stock Option (Right to Buy) | D | 12,15 | 12 250 | 12 250 | |||||
| 2022-01-28 | 2022-01-26 | 4 | Thomson Mary Christina | SRRA | Stock Option (Right to Buy) | D | 13,04 | 2 000 | 0 | |||||
| 2022-01-28 | 2022-01-26 | 4 | Thomson Mary Christina | SRRA | Common Stock | D | 29,0000 | −2 000 | −58 | 0 | ||||
| 2022-01-28 | 2022-01-26 | 4 | Thomson Mary Christina | SRRA | Common Stock | D | 13,0400 | 2 000 | 26 | 2 000 | ||||
| 2022-01-28 | 2022-01-28 | 4 | Turner William D. | SRRA | Stock Option (Right to Buy) | D | 12,15 | 12 250 | 12 250 | |||||
| 2022-01-28 | 2022-01-26 | 4 | Turner William D. | SRRA | Stock Option (Right to Buy) | D | 12,05 | 5 000 | 0 | |||||
| 2022-01-28 | 2022-01-26 | 4 | Turner William D. | SRRA | Common Stock | D | 27,0500 | −5 000 | −135 | 0 | ||||
| 2022-01-28 | 2022-01-26 | 4 | Turner William D. | SRRA | Common Stock | D | 12,0500 | 5 000 | 60 | 5 000 | ||||
| 2022-01-27 | 2022-01-25 | 4 | Longitude Capital Partners III, LLC | SRRA | Series B Warrants | I | 13,20 | 13,2000 | −1 477 125 | −19 498 | 0 | |||
| 2022-01-27 | 2022-01-25 | 4 | Longitude Capital Partners III, LLC | SRRA | Common Stock | I | 13,2000 | 487 451 | 6 434 | 1 964 771 | ||||
| 2022-01-27 | 2022-01-25 | 4 | Richardson Joshua By Longitude Venture Partners III, L.P. | SRRA | Series B Warrants | I | 13,20 | 13,2000 | −1 477 125 | −19 498 | 0 | |||
| 2022-01-27 | 2022-01-25 | 4 | Richardson Joshua By Longitude Venture Partners III, L.P. | SRRA | Common Stock | I | 13,2000 | 487 451 | 6 434 | 1 964 771 | ||||
| 2021-11-24 | 2021-11-24 | 4 | Collard Craig A | SRRA | Common Stock | D | 23,0850 | 7 899 | 182 | 13 500 | ||||
| 2021-11-24 | 2021-11-23 | 4 | Collard Craig A | SRRA | Common Stock | D | 22,9450 | 5 601 | 129 | 5 601 | ||||
| 2021-11-05 | 3 | Abingworth LLP | SRRA | Common Stock, $0.001 par value | I | 878 656 | ||||||||
| 2021-06-28 | 2021-03-15 | 4 | Thomson Mary Christina | SRRA | Stock Option (Right to Buy) | D | 16,73 | 12 900 | 12 900 | |||||
| 2021-06-28 | 2020-07-28 | 4 | Thomson Mary Christina | SRRA | Stock option (right to buy) | D | 13,04 | 100 000 | 100 000 | |||||
| 2021-06-09 | 2021-06-08 | 4 | Cooper Jeffrey H | SRRA | Stock Option (Right To Buy) | D | 18,11 | 6 000 | 6 000 | |||||
| 2021-06-09 | 2021-06-08 | 4 | Collard Craig A | SRRA | Stock Option (Right To Buy) | D | 18,11 | 6 000 | 6 000 | |||||
| 2021-06-09 | 2021-06-08 | 4 | Pelzer Robert | SRRA | Stock Option (Right To Buy) | D | 18,11 | 6 000 | 6 000 | |||||
| 2021-06-09 | 2021-06-08 | 4 | Ashiya Mona | SRRA | Stock Option (Right To Buy) | D | 18,11 | 6 000 | 6 000 | |||||
| 2021-06-09 | 2021-06-08 | 4 | Allen Andrew R | SRRA | Stock Option (Right To Buy) | D | 18,11 | 6 000 | 6 000 | |||||
| 2021-06-09 | 2021-06-08 | 4 | Aggarwal Gaurav | SRRA | Stock Option (Right To Buy) | D | 18,11 | 6 000 | 6 000 | |||||
| 2021-06-09 | 2021-06-08 | 4 | Sinclair Andrew | SRRA | Stock Option (Right To Buy) | D | 18,11 | 6 000 | 6 000 | |||||
| 2021-06-09 | 2021-06-08 | 4 | Richardson Joshua | SRRA | Stock Option (Right To Buy) | D | 18,11 | 6 000 | 6 000 | |||||
| 2021-06-04 | 2021-06-02 | 4 | Oliger Christy J. | SRRA | Stock Option (right to buy) | D | 17,76 | 18 000 | 18 000 | |||||
| 2021-06-04 | 2021-06-02 | 4 | Erbez Georgia | SRRA | Stock Option (right to buy) | D | 17,76 | 18 000 | 18 000 | |||||
| 2021-05-20 | 2021-05-19 | 4 | DILLY STEPHEN GEORGE | SRRA | Common Stock | D | 17,8300 | 5 000 | 89 | 5 000 | ||||
| 2021-03-17 | 2021-03-15 | 4 | Turner William D. | SRRA | Stock Option (Right to Buy) | D | 16,73 | 12 300 | 12 300 | |||||
| 2021-03-17 | 2021-03-15 | 4 | Thomson Christina | SRRA | Stock Option (Right to Buy) | D | 16,73 | 12 900 | 12 900 | |||||
| 2021-03-17 | 2021-03-15 | 4 | Norrett Kevin | SRRA | Stock Option (Right to Buy) | D | 16,73 | 11 700 | 11 700 | |||||
| 2021-03-17 | 2021-03-15 | 4 | Kowalski Mark | SRRA | Stock Option (Right to Buy) | D | 16,73 | 30 000 | 30 000 | |||||
| 2021-03-17 | 2021-03-15 | 4 | Jagpal Sukhi | SRRA | Stock Option (Right to Buy) | D | 16,73 | 30 000 | 30 000 | |||||
| 2021-03-17 | 2021-03-15 | 4 | Klencke Barbara | SRRA | Stock Option (Right to Buy) | D | 16,73 | 30 000 | 30 000 | |||||
| 2021-03-17 | 2021-03-15 | 4 | DILLY STEPHEN GEORGE | SRRA | Stock Option (Right to Buy) | D | 16,73 | 92 000 | 92 000 | |||||
| 2020-08-18 | 2020-08-18 | 4 | Klencke Barbara By spouse | SRRA | Common Stock | I | 12,2519 | 3 325 | 41 | 5 000 | ||||
| 2020-08-18 | 2020-08-18 | 4 | Klencke Barbara | SRRA | Common Stock | D | 12,2201 | 5 950 | 73 | 10 000 | ||||
| 2020-08-12 | 2020-08-12 | 4 | Jagpal Sukhi | SRRA | Stock Option (right to buy) | D | 12,15 | 5 887 | 5 887 | |||||
| 2020-08-12 | 2020-08-12 | 4 | Kowalski Mark | SRRA | Stock Option (right to buy) | D | 12,15 | 24 970 | 24 970 | |||||
| 2020-08-11 | 2020-08-10 | 4 | Norrett Kevin | SRRA | Stock option (right to buy) | D | 12,05 | 100 000 | 100 000 | |||||
| 2020-08-06 | 2020-08-04 | 4 | Turner William D. | SRRA | Stock option (right to buy) | D | 12,05 | 100 000 | 100 000 | |||||
| 2020-07-29 | 2020-07-28 | 4 | Thomson Christina | SRRA | Stock option (right to buy) | D | 13,04 | 100 000 | 100 000 | |||||
| 2020-06-10 | 2020-06-09 | 4 | Aggarwal Gaurav | SRRA | Stock Option (right to buy) | D | 13,98 | 6 874 | 6 874 | |||||
| 2020-06-10 | 2020-06-09 | 4 | Allen Andrew R | SRRA | Stock Option (right to buy) | D | 13,98 | 12 030 | 12 030 | |||||
| 2020-06-10 | 2020-06-09 | 4 | Ashiya Mona | SRRA | Stock Option (right to buy) | D | 13,98 | 6 874 | 6 874 | |||||
| 2020-06-10 | 2020-06-09 | 4 | Cooper Jeffrey H | SRRA | Stock Option (right to buy) | D | 13,98 | 18 061 | 18 061 | |||||
| 2020-06-10 | 2020-06-09 | 4 | Pelzer Robert | SRRA | Stock Option (right to buy) | D | 13,98 | 16 686 | 16 686 | |||||
| 2020-06-10 | 2020-06-09 | 4 | Richardson Joshua | SRRA | Stock Option (right to buy) | D | 13,98 | 6 874 | 6 874 | |||||
| 2020-06-10 | 2020-06-09 | 4 | Sinclair Andrew | SRRA | Stock Option (right to buy | D | 13,98 | 6 874 | 6 874 | |||||
| 2020-06-02 | 2020-06-01 | 4 | DILLY STEPHEN GEORGE | SRRA | Stock Option (right to buy) | D | 14,03 | 520 000 | 520 000 | |||||
| 2020-05-29 | 2020-05-28 | 4 | Collard Craig A | SRRA | Stock Option (right to buy) | D | 13,88 | 10 000 | 10 000 | |||||
| 2020-02-27 | 2020-02-25 | 4 | Glover Nicholas | SRRA | Stock Option (right to buy) | D | 13,31 | 359 158 | 359 158 | |||||
| 2020-02-27 | 2020-02-25 | 4 | Jagpal Sukhi | SRRA | Stock Option (right to buy) | D | 13,31 | 94 113 | 94 113 | |||||
| 2020-02-27 | 2020-02-25 | 4 | Klencke Barbara | SRRA | Stock Option (right to buy) | D | 13,31 | 167 091 | 167 091 | |||||
| 2020-02-27 | 2020-02-25 | 4 | Kowalski Mark | SRRA | Stock Option (right to buy) | D | 13,31 | 75 030 | 75 030 | |||||
| 2020-02-03 | 2020-01-29 | 4/A | Sinclair Andrew See footnotes | SRRA | Series A Convertible Voting Preferred Stock | I | −11 500 | 0 | ||||||
| 2020-02-03 | 2020-01-29 | 4/A | Sinclair Andrew See footnotes | SRRA | Common Stock | I | 871 240 | 876 656 | ||||||
| 2020-01-31 | 2020-01-29 | 4 | ORBIMED ADVISORS LLC See footnotes | SRRA | Series A Convertible Voting Preferred Stock | I | −19 500 | 0 | ||||||
| 2020-01-31 | 2020-01-29 | 4 | ORBIMED ADVISORS LLC See footnotes | SRRA | Common Stock | I | 1 477 320 | 1 477 320 | ||||||
| 2020-01-31 | 2020-01-29 | 4 | Aggarwal Gaurav By Vivo Opportunity Fund, LP | SRRA | Series A Convertible Voting Preferred Stock | I | −19 213 | 0 | ||||||
| 2020-01-31 | 2020-01-29 | 4 | Aggarwal Gaurav By Vivo Opportunity Fund, LP | SRRA | Common Stock | I | 1 455 576 | 1 455 576 | ||||||
| 2020-01-31 | 2020-01-29 | 4 | Ashiya Mona See footnotes | SRRA | Series A Convertible Voting Preferred Stock | I | −19 500 | 0 | ||||||
| 2020-01-31 | 2020-01-29 | 4 | Ashiya Mona See footnotes | SRRA | Common Stock | I | 1 477 320 | 1 477 320 | ||||||
| 2020-01-31 | 2020-01-29 | 4 | Richardson Joshua By Longitude Venture Partners III, L.P. | SRRA | Series A Convertible Voting Preferred Stock | I | −19 500 | 0 | ||||||
| 2020-01-31 | 2020-01-29 | 4 | Richardson Joshua By Longitude Venture Partners III, L.P. | SRRA | Common Stock | I | 1 477 320 | 1 477 320 | ||||||
| 2020-01-31 | 2020-01-29 | 4 | Longitude Capital Partners III, LLC | SRRA | Series A Convertible Voting Preferred Stock | I | −19 500 | 0 | ||||||
| 2020-01-31 | 2020-01-29 | 4 | Longitude Capital Partners III, LLC | SRRA | Common Stock | I | 1 477 320 | 1 477 320 | ||||||
| 2020-01-31 | 2020-01-29 | 4 | Vivo Opportunity, LLC By: Vivo Capital Fund IX, L.P. | SRRA | Series A Convertible Voting Preferred Stock | I | −4 287 | 0 | ||||||
| 2020-01-31 | 2020-01-29 | 4 | Vivo Opportunity, LLC By Vivo Opportunity Fund, L.P. | SRRA | Series A Convertible Voting Preferred Stock | I | −19 213 | 0 | ||||||
| 2020-01-31 | 2020-01-29 | 4 | Vivo Opportunity, LLC By: Vivo Ventures Fund VII, L.P. and Vivo Ventures VII Affiliates Fund, L.P. | SRRA | Series A Convertible Voting Preferred Stock | I | −1 000 | 0 | ||||||
| 2020-01-31 | 2020-01-29 | 4 | Vivo Opportunity, LLC By: Vivo Capital Fund IX, L.P. | SRRA | Common Stock | I | 324 783 | 324 783 | ||||||
| 2020-01-31 | 2020-01-29 | 4 | Vivo Opportunity, LLC By Vivo Opportunity Fund, L.P. | SRRA | Common Stock | I | 1 455 576 | 1 455 576 | ||||||
| 2020-01-31 | 2020-01-29 | 4 | Vivo Opportunity, LLC By: Vivo Ventures Fund VII, L.P. and Vivo Ventures VII Affiliates Fund, L.P. | SRRA | Common Stock | I | 75 759 | 136 715 | ||||||
| 2020-01-31 | 2020-01-29 | 4 | Sinclair Andrew See footnotes | SRRA | Series A Convertible Voting Preferred Stock | I | −11 500 | 0 | ||||||
| 2020-01-31 | 2020-01-29 | 4 | Sinclair Andrew See footnotes | SRRA | Common Stock | I | 871 125 | 876 542 | ||||||
| 2019-12-03 | 2019-11-29 | 4 | Sinclair Andrew | SRRA | Stock Option (right to buy) | D | 0,35 | 60 000 | 60 000 | |||||
| 2019-12-03 | 2019-11-29 | 4 | Aggarwal Gaurav | SRRA | Stock Option (Right to Buy) | D | 0,35 | 60 000 | 60 000 | |||||
| 2019-12-03 | 2019-11-29 | 4 | Ashiya Mona | SRRA | Stock Option (Right to Buy) | D | 0,35 | 60 000 | 60 000 | |||||
| 2019-12-03 | 2019-11-29 | 4 | Richardson Joshua | SRRA | Stock Option (Right to Buy) | D | 0,35 | 60 000 | 60 000 | |||||
| 2019-12-02 | 3 | Vivo Ventures VII Affiliates Fund, L.P. By: Vivo Ventures Fund VII, L.P. and Vivo Ventures VII Affiliates Fund, L.P. | SRRA | Common Stock | I | 4 876 540 | ||||||||
| 2019-12-02 | 3 | Vivo Ventures VII Affiliates Fund, L.P. By: Vivo Ventures Fund VII, L.P. and Vivo Ventures VII Affiliates Fund, L.P. | SRRA | Common Stock | I | 4 876 540 | ||||||||
| 2019-12-02 | 3 | Vivo Ventures VII Affiliates Fund, L.P. By: Vivo Ventures Fund VII, L.P. and Vivo Ventures VII Affiliates Fund, L.P. | SRRA | Common Stock | I | 4 876 540 | ||||||||
| 2019-12-02 | 3 | Vivo Ventures VII Affiliates Fund, L.P. By: Vivo Ventures Fund VII, L.P. and Vivo Ventures VII Affiliates Fund, L.P. | SRRA | Common Stock | I | 4 876 540 | ||||||||
| 2019-12-02 | 3 | Vivo Ventures VII Affiliates Fund, L.P. By: Vivo Ventures Fund VII, L.P. and Vivo Ventures VII Affiliates Fund, L.P. | SRRA | Common Stock | I | 4 876 540 | ||||||||
| 2019-12-02 | 3 | Vivo Ventures VII Affiliates Fund, L.P. By: Vivo Ventures Fund VII, L.P. and Vivo Ventures VII Affiliates Fund, L.P. | SRRA | Common Stock | I | 4 876 540 | ||||||||
| 2019-12-02 | 3 | Vivo Ventures VII Affiliates Fund, L.P. By: Vivo Ventures Fund VII, L.P. and Vivo Ventures VII Affiliates Fund, L.P. | SRRA | Common Stock | I | 4 876 540 | ||||||||
| 2019-12-02 | 3 | Vivo Ventures VII Affiliates Fund, L.P. By: Vivo Ventures Fund VII, L.P. and Vivo Ventures VII Affiliates Fund, L.P. | SRRA | Common Stock | I | 4 876 540 | ||||||||
| 2019-12-02 | 3 | Vivo Ventures VII Affiliates Fund, L.P. By: Vivo Ventures Fund VII, L.P. and Vivo Ventures VII Affiliates Fund, L.P. | SRRA | Common Stock | I | 4 876 540 | ||||||||
| 2019-11-26 | 3 | Sinclair Andrew See Footnotes | SRRA | Common Stock, $0.001 par value | I | 433 334 | ||||||||
| 2019-11-26 | 3 | Sinclair Andrew See Footnotes | SRRA | Common Stock, $0.001 par value | I | 433 334 | ||||||||
| 2019-11-26 | 3 | Sinclair Andrew See Footnotes | SRRA | Common Stock, $0.001 par value | I | 433 334 | ||||||||
| 2019-08-26 | 2019-08-23 | 4 | Klencke Barbara | SRRA | Common Stock | D | 0,4387 | 108 000 | 47 | 162 000 | ||||
| 2019-08-26 | 2019-08-22 | 4 | Klencke Barbara | SRRA | Common Stock | D | 0,4499 | 54 000 | 24 | 54 000 | ||||
| 2019-08-26 | 2019-08-22 | 4 | Klencke Barbara By spouse | SRRA | Common Stock | I | 0,4323 | 67 000 | 29 | 67 000 | ||||
| 2019-06-12 | 2019-06-11 | 4 | Cooper Jeffrey H | SRRA | Stock Option (right to buy) | D | 0,66 | 30 000 | 30 000 | |||||
| 2019-06-12 | 2019-06-11 | 4 | ESTES DANIEL | SRRA | Stock Option (right to buy) | D | 0,66 | 30 000 | 30 000 | |||||
| 2019-06-12 | 2019-06-11 | 4 | Nguyen Tran | SRRA | Stock Option (right to buy) | D | 0,66 | 30 000 | 30 000 | |||||
| 2019-06-12 | 2019-06-11 | 4 | ONETTO NICOLE | SRRA | Stock Option (right to buy) | D | 0,66 | 30 000 | 30 000 | |||||
| 2019-06-12 | 2019-06-11 | 4 | Parfet Donald R | SRRA | Stock Option (right to buy) | D | 0,66 | 30 000 | 30 000 | |||||
| 2019-06-12 | 2019-06-11 | 4 | Pelzer Robert | SRRA | Stock Option (right to buy) | D | 0,66 | 30 000 | 30 000 | |||||
| 2019-06-12 | 2019-06-11 | 4 | Allen Andrew R | SRRA | Stock Option (right to buy) | D | 0,66 | 30 000 | 30 000 | |||||
| 2019-03-05 | 2019-03-04 | 4 | Glover Nicholas | SRRA | Stock Option (right to buy) | D | 1,96 | 607 500 | 607 500 | |||||
| 2019-03-05 | 2019-03-04 | 4 | Hassig Christian | SRRA | Stock Option (right to buy) | D | 1,96 | 155 000 | 155 000 | |||||
| 2019-03-05 | 2019-03-04 | 4 | Jagpal Sukhi | SRRA | Stock Option (right to buy) | D | 1,96 | 200 000 | 200 000 | |||||
| 2019-03-05 | 2019-03-04 | 4 | Klencke Barbara | SRRA | Stock Option (right to buy) | D | 1,96 | 200 000 | 200 000 | |||||
| 2019-03-05 | 2019-03-04 | 4 | Kowalski Mark | SRRA | Stock Option (right to buy) | D | 1,96 | 200 000 | 200 000 | |||||
| 2018-12-11 | 2018-12-10 | 4 | Allen Andrew R | SRRA | Common Stock | D | 1,6400 | 66 000 | 108 | 66 000 | ||||
| 2018-06-14 | 2018-06-12 | 4 | Pelzer Robert | SRRA | Stock Option (right to buy) | D | 3,27 | 25 000 | 25 000 | |||||
| 2018-06-14 | 2018-06-12 | 4 | ESTES DANIEL | SRRA | Stock Option (right to buy) | D | 3,27 | 25 000 | 25 000 | |||||
| 2018-06-14 | 2018-06-12 | 4 | Allen Andrew R | SRRA | Stock Option (right to buy) | D | 3,27 | 25 000 | 25 000 | |||||
| 2018-06-14 | 2018-06-12 | 4 | Cooper Jeffrey H | SRRA | Stock Option (right to buy) | D | 3,27 | 25 000 | 25 000 | |||||
| 2018-06-14 | 2018-06-12 | 4 | Nguyen Tran | SRRA | Stock Option (right to buy) | D | 3,27 | 25 000 | 25 000 | |||||
| 2018-06-14 | 2018-06-12 | 4 | ONETTO NICOLE | SRRA | Stock Option (right to buy) | D | 3,27 | 25 000 | 25 000 | |||||
| 2018-06-14 | 2018-06-12 | 4 | Parfet Donald R | SRRA | Stock Option (right to buy) | D | 3,27 | 25 000 | 25 000 | |||||
| 2018-03-07 | 2018-03-06 | 4 | Glover Nicholas | SRRA | Stock Option (right to buy) | D | 2,36 | 562 780 | 562 780 | |||||
| 2018-03-07 | 2018-03-06 | 4 | Hassig Christian | SRRA | Stock Option (right to buy) | D | 2,36 | 205 180 | 205 180 | |||||
| 2018-03-07 | 2018-03-06 | 4 | Jagpal Sukhi | SRRA | Stock Option (right to buy) | D | 2,36 | 180 360 | 180 360 | |||||
| 2018-03-07 | 2018-03-06 | 4 | Klencke Barbara | SRRA | Stock Option (right to buy) | D | 2,36 | 180 360 | 180 360 | |||||
| 2018-03-07 | 2018-03-06 | 4 | Kowalski Mark | SRRA | Stock Option (right to buy) | D | 2,36 | 155 000 | 155 000 | |||||
| 2018-03-07 | 2018-03-06 | 4 | You Angie | SRRA | Stock Option (right to buy) | D | 2,36 | 180 360 | 180 360 | |||||
| 2018-01-08 | 2018-01-04 | 4 | Parfet Donald R | SRRA | Common Stock | D | 1 380 | 77 235 | ||||||
| 2018-01-08 | 2018-01-04 | 4 | Parfet Donald R Apjohn Ventures, LLC | SRRA | Common Stock | I | −2 760 | 0 | ||||||
| 2018-01-08 | 2018-01-04 | 4 | Parfet Donald R Apjohn Ventures, LLC | SRRA | Common Stock | I | 1 068 | 2 760 | ||||||
| 2018-01-08 | 2018-01-04 | 4 | Parfet Donald R Apjohn Ventures, LLC | SRRA | Common Stock | I | 1 692 | 1 692 | ||||||
| 2018-01-08 | 2018-01-04 | 4 | Parfet Donald R By Donald R. Parfet 2006 Trust, Dated May 1, 2006 | SRRA | Common Stock | I | 3 383 | 390 913 | ||||||
| 2017-11-13 | 2017-11-10 | 4 | Allen Andrew R | SRRA | Stock Option (Right to Buy) | D | 1,92 | 50 000 | 50 000 | |||||
| 2017-10-25 | 3 | Allen Andrew R | SRRA | No securities beneficially owned. | D | 0 | ||||||||
| 2017-06-14 | 2017-06-13 | 4 | Cooper Jeffrey H | SRRA | Stock Option (right to buy) | D | 1,13 | 25 000 | 25 000 | |||||
| 2017-06-14 | 2017-06-13 | 4 | Nguyen Tran | SRRA | Stock Option (right to buy) | D | 1,13 | 25 000 | 25 000 | |||||
| 2017-06-14 | 2017-06-13 | 4 | ONETTO NICOLE | SRRA | Stock Option (right to buy) | D | 1,13 | 25 000 | 25 000 | |||||
| 2017-06-14 | 2017-06-13 | 4 | Parfet Donald R | SRRA | Stock Option (right to buy) | D | 1,13 | 25 000 | 25 000 | |||||
| 2017-06-14 | 2017-06-13 | 4 | Pelzer Robert | SRRA | Stock Option (right to buy) | D | 1,13 | 25 000 | 25 000 | |||||
| 2017-05-30 | 2017-05-25 | 4 | ESTES DANIEL | SRRA | Stock Option (Right to Buy) | D | 1,20 | 50 000 | 50 000 | |||||
| 2017-04-11 | 3 | ESTES DANIEL | SRRA | No securities beneficially owned | D | 0 | ||||||||
| 2017-03-09 | 2017-03-08 | 4 | You Angie | SRRA | Common Stock | D | 1,4300 | 30 000 | 43 | 133 252 | ||||
| 2017-03-08 | 2017-03-06 | 4 | You Angie | SRRA | Stock Option (right to buy) | D | 1,45 | 70 000 | 70 000 | |||||
| 2017-03-08 | 2017-03-06 | 4 | Jagpal Sukhi | SRRA | Stock Option (right to buy) | D | 1,45 | 70 000 | 70 000 | |||||
| 2017-03-08 | 2017-03-06 | 4 | Klencke Barbara | SRRA | Stock Option (right to buy) | D | 1,45 | 70 000 | 70 000 | |||||
| 2017-03-08 | 2017-03-06 | 4 | Glover Nicholas | SRRA | Stock Option (right to buy) | D | 1,45 | 195 000 | 195 000 | |||||
| 2017-02-24 | 3 | Heron Patrick J | SRRA | Common Stock | D | 10 298 316 | ||||||||
| 2017-02-24 | 3 | Heron Patrick J | SRRA | Common Stock | D | 14 038 047 | ||||||||
| 2017-02-24 | 3 | Heron Patrick J | SRRA | Common Stock | D | 10 298 316 | ||||||||
| 2017-02-24 | 3 | Heron Patrick J | SRRA | Common Stock | D | 14 038 047 | ||||||||
| 2017-02-24 | 3 | Heron Patrick J | SRRA | Common Stock | D | 10 298 316 | ||||||||
| 2017-02-24 | 3 | Heron Patrick J | SRRA | Common Stock | D | 14 038 047 | ||||||||
| 2017-02-24 | 3 | Heron Patrick J | SRRA | Common Stock | D | 10 298 316 | ||||||||
| 2017-02-24 | 3 | Heron Patrick J | SRRA | Common Stock | D | 14 038 047 | ||||||||
| 2017-02-24 | 3 | Heron Patrick J | SRRA | Common Stock | D | 10 298 316 | ||||||||
| 2017-02-24 | 3 | Heron Patrick J | SRRA | Common Stock | D | 14 038 047 | ||||||||
| 2017-02-24 | 3 | Heron Patrick J | SRRA | Common Stock | D | 10 298 316 | ||||||||
| 2017-02-24 | 3 | Heron Patrick J | SRRA | Common Stock | D | 14 038 047 | ||||||||
| 2017-02-24 | 3 | Heron Patrick J | SRRA | Common Stock | D | 10 298 316 | ||||||||
| 2017-02-24 | 3 | Heron Patrick J | SRRA | Common Stock | D | 14 038 047 | ||||||||
| 2017-02-24 | 3 | Heron Patrick J | SRRA | Common Stock | D | 10 298 316 | ||||||||
| 2017-02-24 | 3 | Heron Patrick J | SRRA | Common Stock | D | 14 038 047 | ||||||||
| 2017-02-24 | 3 | Heron Patrick J | SRRA | Common Stock | D | 14 038 047 | ||||||||
| 2017-02-24 | 3 | Heron Patrick J | SRRA | Common Stock | D | 14 038 047 | ||||||||
| 2017-02-24 | 3 | Heron Patrick J | SRRA | Common Stock | D | 10 298 316 | ||||||||
| 2017-02-24 | 3 | Heron Patrick J | SRRA | Common Stock | D | 14 038 047 | ||||||||
| 2017-02-24 | 3 | Heron Patrick J | SRRA | Common Stock | D | 10 298 316 | ||||||||
| 2017-02-24 | 3 | Heron Patrick J | SRRA | Common Stock | D | 10 298 316 | ||||||||
| 2017-02-16 | 2017-02-14 | 4 | Topper James N By Frazier Life Sciences VIII, L.P. | SRRA | Common Stock | I | 1,3500 | 5 925 926 | 8 000 | 5 925 926 | ||||
| 2017-01-04 | 3 | Kowalski Mark | DNAI | No securities beneficially held | D | 0 | ||||||||
| 2017-01-04 | 2017-01-03 | 4 | Kowalski Mark | DNAI | Stock Option (right to buy Class A Common Stock) | D | 1,54 | 300 000 | 300 000 | |||||
| 2016-11-10 | 2016-11-08 | 4 | Parfet Donald R | DNAI | Common Stock | D | 2 403 | 75 855 | ||||||
| 2016-11-10 | 2016-11-08 | 4 | Parfet Donald R Apjohn Ventures, LLC | DNAI | Common Stock | I | −4 806 | 0 | ||||||
| 2016-11-10 | 2016-11-08 | 4 | Parfet Donald R Apjohn Ventures, LLC | DNAI | Common Stock | I | 1 423 | 4 806 | ||||||
| 2016-11-10 | 2016-11-08 | 4 | Parfet Donald R Apjohn Ventures, LLC | DNAI | Common Stock | I | 3 383 | 3 383 | ||||||
| 2016-11-10 | 2016-11-08 | 4 | Parfet Donald R By Donald R. Parfet 2006 Trust, Dated May 1, 2006 | DNAI | Common Stock | I | 6 767 | 387 530 | ||||||
| 2016-10-04 | 2016-09-30 | 4 | Jagpal Sukhi | DNAI | Stock Option (right to buy) | D | 1,82 | 168 000 | 168 000 | |||||
| 2016-10-04 | 2016-09-30 | 4 | Glover Nicholas | DNAI | Stock Option (right to buy) | D | 1,82 | 500 000 | 500 000 | |||||
| 2016-10-04 | 2016-09-30 | 4 | Klencke Barbara | DNAI | Stock Option (right to buy) | D | 1,82 | 456 000 | 456 000 | |||||
| 2016-10-04 | 2016-09-30 | 4 | You Angie | DNAI | Stock Option (right to buy) | D | 1,82 | 200 000 | 200 000 | |||||
| 2016-09-30 | 2016-09-29 | 4 | Parfet Donald R | DNAI | Common Stock | D | 1 202 | 73 452 | ||||||
| 2016-09-30 | 2016-09-29 | 4 | Parfet Donald R By Apjohn Ventures, LLC | DNAI | Common Stock | I | −2 403 | 0 | ||||||
| 2016-09-30 | 2016-09-29 | 4 | Parfet Donald R By Apjohn Ventures, LLC | DNAI | Common Stock | I | 711 | 2 403 | ||||||
| 2016-09-30 | 2016-09-29 | 4 | Parfet Donald R By Apjohn Ventures, LLC | DNAI | Common Stock | I | 1 692 | 1 692 | ||||||
| 2016-09-30 | 2016-09-29 | 4 | Parfet Donald R By Donald R. Parfet 2006 Trust, Dated May 1, 2006 | DNAI | Common Stock | I | 3 384 | 380 763 | ||||||
| 2016-06-20 | 2016-06-16 | 4 | ONETTO NICOLE | DNAI | Stock Option (right to buy) | D | 2,06 | 38 835 | 38 835 | |||||
| 2016-06-20 | 2016-06-16 | 4 | Pelzer Robert | DNAI | Stock Option (right to buy) | D | 2,06 | 38 835 | 38 835 | |||||
| 2016-06-20 | 2016-06-16 | 4 | Parfet Donald R | DNAI | Stock Option (right to buy) | D | 2,06 | 38 835 | 38 835 | |||||
| 2016-06-20 | 2016-06-16 | 4 | Topper James N | DNAI | Stock Option (right to buy) | D | 2,06 | 38 835 | 38 835 | |||||
| 2016-06-13 | 2016-06-09 | 4 | Cooper Jeffrey H | DNAI | Stock Option (right to buy) | D | 2,06 | 77 670 | 77 670 | |||||
| 2016-06-13 | 2016-06-09 | 4 | Nguyen Tran | DNAI | Stock Option (right to buy) | D | 2,06 | 77 670 | 77 670 | |||||
| 2016-05-17 | 2016-05-13 | 4 | Parfet Donald R By Donald R. Parfet 2006 Trust, Dated May 1, 2006 | DNAI | Common Stock | I | 3 204 | 377 379 | ||||||
| 2016-03-24 | 3 | Nguyen Tran | DNAI | No securities beneficially held | D | 0 | ||||||||
| 2016-03-24 | 3 | Cooper Jeffrey H | DNAI | No securities beneficially held | D | 0 | ||||||||
| 2016-03-24 | 2016-03-22 | 4 | Chapman Wendy | DNAI | Stock Option (right to buy) | D | 0,97 | −3 000 | 76 248 | |||||
| 2016-03-24 | 2016-03-22 | 4 | Chapman Wendy | DNAI | Common Stock | D | 7,0078 | −3 000 | −21 | 0 | ||||
| 2016-03-24 | 2016-03-22 | 4 | Chapman Wendy | DNAI | Common Stock | D | 0,9690 | 3 000 | 3 | 3 000 | ||||
| 2016-03-10 | 2016-03-08 | 4 | Messmann Richard A | DNAI | Stock Option (right to buy) | D | 6,58 | 25 000 | 25 000 | |||||
| 2016-03-10 | 2016-03-08 | 4 | Lovejoy Chandra D | DNAI | Stock Option (right to buy) | D | 6,58 | 31 000 | 31 000 | |||||
| 2016-03-10 | 2016-03-08 | 4 | Jagpal Sukhi | DNAI | Stock Option (right to buy) | D | 6,58 | 48 750 | 48 750 | |||||
| 2016-03-10 | 2016-03-08 | 4 | Glover Nicholas | DNAI | Stock Option (right to buy) | D | 6,58 | 161 250 | 161 250 | |||||
| 2016-03-10 | 2016-03-08 | 4 | Klencke Barbara | DNAI | Stock Option (right to buy) | D | 6,58 | 82 500 | 82 500 | |||||
| 2016-03-10 | 2016-03-08 | 4 | Chapman Wendy | DNAI | Stock Option (right to buy) | D | 6,58 | 25 000 | 25 000 | |||||
| 2016-03-10 | 2016-03-08 | 4 | You Angie | DNAI | Stock Option (right to buy) | D | 6,58 | 75 000 | 75 000 | |||||
| 2016-02-24 | 2016-02-22 | 4 | Chapman Wendy | DNAI | Stock Option (right to buy) | D | 0,97 | −3 000 | 79 248 | |||||
| 2016-02-24 | 2016-02-22 | 4 | Chapman Wendy | DNAI | Common Stock | D | 7,0600 | −3 000 | −21 | 0 | ||||
| 2016-02-24 | 2016-02-22 | 4 | Chapman Wendy | DNAI | Common Stock | D | 0,9690 | 3 000 | 3 | 3 000 | ||||
| 2016-01-25 | 2016-01-22 | 4 | Chapman Wendy | DNAI | Stock Option (right to buy) | D | 0,97 | −5 000 | 82 248 | |||||
| 2016-01-25 | 2016-01-22 | 4 | Chapman Wendy | DNAI | Common Stock | D | 9,3946 | −5 000 | −47 | 0 | ||||
| 2016-01-25 | 2016-01-22 | 4 | Chapman Wendy | DNAI | Common Stock | D | 0,9690 | 5 000 | 5 | 5 000 | ||||
| 2016-01-22 | 2016-01-22 | 4 | Rodigueza Wendi | DNAI | Common Stock | D | 9,6600 | −1 000 | −10 | 156 276 | ||||
| 2016-01-22 | 2016-01-21 | 4 | Rodigueza Wendi | DNAI | Common Stock | D | 10,3230 | −1 000 | −10 | 157 276 | ||||
| 2016-01-22 | 2016-01-20 | 4 | Rodigueza Wendi | DNAI | Common Stock | D | 9,5900 | −1 000 | −10 | 158 276 | ||||
| 2016-01-19 | 2016-01-15 | 4 | Glover Nicholas | DNAI | Stock Option (right to buy) | D | 0,97 | −5 000 | 864 219 | |||||
| 2016-01-19 | 2016-01-15 | 4 | Glover Nicholas | DNAI | Common Stock | D | 10,0446 | −5 000 | −50 | 0 | ||||
| 2016-01-19 | 2016-01-15 | 4 | Glover Nicholas | DNAI | Common Stock | D | 0,9690 | 5 000 | 5 | 5 000 | ||||
| 2016-01-14 | 2016-01-12 | 4 | Lovejoy Chandra D | DNAI | Stock Option (right to buy) | D | 0,97 | −7 551 | 46 140 | |||||
| 2016-01-14 | 2016-01-12 | 4 | Lovejoy Chandra D | DNAI | Common Stock | D | 11,9282 | −5 562 | −66 | 0 | ||||
| 2016-01-14 | 2016-01-12 | 4 | Lovejoy Chandra D | DNAI | Common Stock | D | 11,0628 | −15 411 | −170 | 5 562 | ||||
| 2016-01-14 | 2016-01-12 | 4 | Lovejoy Chandra D | DNAI | Common Stock | D | 0,9690 | 7 551 | 7 | 20 973 | ||||
| 2015-12-02 | 3 | Anderson Keith Edward | DNAI | No securities are beneficially owned | D | 0 | ||||||||
| 2015-12-02 | 2015-12-01 | 4 | Anderson Keith Edward | DNAI | Stock Option (right to buy) | D | 18,33 | 100 000 | 100 000 | |||||
| 2015-07-21 | 2015-07-21 | 4 | Vitangcol Alvin By Capital Midwest Fund II, L.P. | DNAI | Series D Preferred Stock | I | −287 631 | 0 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Vitangcol Alvin By Capital Midwest Fund II, L.P. | DNAI | Series C Preferred Stock | I | −471 242 | 0 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Vitangcol Alvin By Capital Midwest Fund II, L.P. | DNAI | Series C Preferred Stock | I | −38 824 | 471 242 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Vitangcol Alvin By Capital Midwest Fund II, L.P. | DNAI | Series C Preferred Stock | I | 126 558 | 510 066 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Vitangcol Alvin By Capital Midwest Fund II, L.P. | DNAI | Series C Preferred Stock Warrant (right to buy) | I | 5,2150 | −126 558 | −660 | 0 | ||||
| 2015-07-21 | 2015-07-21 | 4 | Vitangcol Alvin By Capital Midwest Fund II, L.P. | DNAI | Common Stock | I | 5,2150 | 39 889 | 208 | 798 762 | ||||
| 2015-07-21 | 2015-07-21 | 4 | Vitangcol Alvin By Capital Midwest Fund II, L.P. | DNAI | Common Stock | I | 287 631 | 758 873 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Vitangcol Alvin By Capital Midwest Fund II, L.P. | DNAI | Common Stock | I | 471 242 | 471 242 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Topper James N By Frazier Healthcare VI, L.P. | DNAI | Series D Preferred Stock | I | −1 869 606 | 0 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Topper James N By Frazier Healthcare VI, L.P. | DNAI | Common Stock | I | 17,0000 | 220 000 | 3 740 | 2 186 195 | ||||
| 2015-07-21 | 2015-07-21 | 4 | Topper James N By Frazier Healthcare VI, L.P. | DNAI | Common Stock | I | 5,2150 | 96 589 | 504 | 1 966 195 | ||||
| 2015-07-21 | 2015-07-21 | 4 | Topper James N By Frazier Healthcare VI, L.P. | DNAI | Common Stock | I | 1 869 606 | 1 869 606 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Thompson Peter A. See Footnotes | DNAI | Series D Preferred Stock | I | −1 725 790 | 0 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Thompson Peter A. See Footnotes | DNAI | Common Stock | I | 17,0000 | 175 000 | 2 975 | 1 989 949 | ||||
| 2015-07-21 | 2015-07-21 | 4 | Thompson Peter A. See Footnotes | DNAI | Common Stock | I | 5,2150 | 89 159 | 465 | 1 814 949 | ||||
| 2015-07-21 | 2015-07-21 | 4 | Thompson Peter A. See Footnotes | DNAI | Common Stock | I | 1 725 790 | 1 725 790 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Rodigueza Wendi | DNAI | Series B-1 Preferred Stock | D | −1 966 | 0 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Rodigueza Wendi | DNAI | Common Stock | D | 1 966 | 159 276 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Palmero Group LLC | DNAI | Series C Preferred Stock | I | −13 130 | 0 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Palmero Group LLC | DNAI | Series A Preferred Stock | I | −46 034 | 0 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Donald R. Parfet 2006 Trust, Dated May 1, 2006 | DNAI | Series B-1 Preferred Stock | I | −142 422 | 0 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Donald R. Parfet 2006 Trust, Dated May 1, 2006 | DNAI | Series B Preferred Stock | I | −189 933 | 0 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Donald R. Parfet 2006 Trust, Dated May 1, 2006 | DNAI | Series A Preferred Stock | I | −306 | 0 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Ann VanDeWater Parfet 2006 Revocable Trust, Dated May 5, 2006 | DNAI | Series C Preferred Stock | I | −65 938 | 0 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Ann VanDeWater Parfet 2006 Revocable Trust, Dated May 5, 2006 | DNAI | Series B-1 Preferred Stock | I | −121 242 | 0 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Ann VanDeWater Parfet 2006 Revocable Trust, Dated May 5, 2006 | DNAI | Series B Preferred Stock | I | −23 944 | 0 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By wife | DNAI | Series A Preferred Stock | I | −4 415 | 0 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Apjohn Ventures Fund, LP | DNAI | Series C Preferred Stock | I | −24 277 | 0 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Apjohn Ventures Fund, LP | DNAI | Series C Preferred Stock | I | −221 | 24 277 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Apjohn Ventures Fund, LP | DNAI | Series C Preferred Stock | I | 719 | 24 498 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Apjohn Ventures Fund, LP | DNAI | Series C Preferred Stock Warrant (right to buy) | I | 5,2150 | −719 | −4 | 0 | ||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Apjohn Ventures Fund, LP | DNAI | Series B-1 Preferred Stock | I | −516 203 | 0 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Apjohn Ventures Fund, LP | DNAI | Series B-1 Preferred Stock | I | −2 941 | 516 203 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Apjohn Ventures Fund, LP | DNAI | Series B-1 Preferred Stock | I | 6 711 | 519 144 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Apjohn Ventures Fund, LP | DNAI | Series B-1 Preferred Stock Warrant (right to buy) | I | 7,4500 | −6 711 | −50 | 0 | ||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Apjohn Ventures Fund, LP | DNAI | Series B-1 Preferred Stock | I | −40 729 | 512 433 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R y Apjohn Ventures Fund, LP | DNAI | Series B-1 Preferred Stock | I | 265 536 | 553 162 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Apjohn Ventures Fund, LP | DNAI | Series B-1 Preferred Stock Warrant (right to buy) | I | 2,6080 | −265 536 | −693 | 0 | ||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Apjohn Ventures Fund, LP | DNAI | Series B Preferred Stock | I | −153 485 | 0 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Apjohn Ventures Fund, LP | DNAI | Series A Preferred Stock | I | −26 728 | 0 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Apjohn Ventures Annex Fund LP | DNAI | Series D Preferred Stock | I | −11 505 | 0 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Apjohn Ventures Annex Fund LP | DNAI | Series C Preferred Stock | I | −59 225 | 0 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Apjohn Ventures Annex Fund LP | DNAI | Series B-1 Preferred Stock | I | −67 112 | 0 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Apjohn Group, LLC | DNAI | Series A Preferred Stock | I | −307 | 0 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Palmero Group LLC | DNAI | Common Stock | I | 5,2150 | 819 | 4 | 65 779 | ||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Palmero Group LLC | DNAI | Common Stock | I | 13 130 | 64 960 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Palmero Group LLC | DNAI | Common Stock | I | 51 830 | 51 830 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Donald R. Parfet 2006 Trust, Dated May 1, 2006 | DNAI | Common Stock | I | 142 422 | 353 802 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Donald R. Parfet 2006 Trust, Dated May 1, 2006 | DNAI | Common Stock | I | 211 036 | 211 380 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Donald R. Parfet 2006 Trust, Dated May 1, 2006 | DNAI | Common Stock | I | 344 | 344 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Ann VanDeWater Parfet 2006 Revocable Trust, Dated May 5, 2006 | DNAI | Common Stock | I | 5,2150 | 4 119 | 21 | 217 903 | ||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Ann VanDeWater Parfet 2006 Revocable Trust, Dated May 5, 2006 | DNAI | Common Stock | I | 65 938 | 213 784 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Ann VanDeWater Parfet 2006 Revocable Trust, Dated May 5, 2006 | DNAI | Common Stock | I | 121 242 | 147 846 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Ann VanDeWater Parfet 2006 Revocable Trust, Dated May 5, 2006 | DNAI | Common Stock | I | 26 604 | 26 604 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By wife | DNAI | Common Stock | I | 4 970 | 4 970 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Apjohn Ventures Fund, LP | DNAI | Common Stock | I | 5,2150 | 1 552 | 8 | 770 045 | ||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Apjohn Ventures Fund, LP | DNAI | Common Stock | I | 24 277 | 768 493 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Apjohn Ventures Fund, LP | DNAI | Common Stock | I | 516 203 | 744 216 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Apjohn Ventures Fund, LP | DNAI | Common Stock | I | 170 538 | 228 013 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Apjohn Ventures Fund, LP | DNAI | Common Stock | I | 30 093 | 57 475 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Apjohn Ventures Annex Fund LP | DNAI | Common Stock | I | 5,2150 | 4 413 | 23 | 142 255 | ||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Apjohn Ventures Annex Fund LP | DNAI | Common Stock | I | 11 505 | 137 842 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Apjohn Ventures Annex Fund LP | DNAI | Common Stock | I | 59 225 | 126 337 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Apjohn Ventures Annex Fund LP | DNAI | Common Stock | I | 67 112 | 67 112 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Apjohn Group, LLC | DNAI | Common Stock | I | 345 | 589 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | VIVO VENTURES VII, LLC By Vivo Ventures VII Affiliates Fund, L.P. | DNAI | Series D Preferred Stock | I | −44 991 | 0 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | VIVO VENTURES VII, LLC By Vivo Ventures Fund VII, L.P. | DNAI | Series D Preferred Stock | I | −2 064 308 | 0 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | VIVO VENTURES VII, LLC By Vivo Ventures VII Affiliates Fund, L.P. | DNAI | Common Stock | I | 17,0000 | 4 693 | 80 | 2 438 270 | ||||
| 2015-07-21 | 2015-07-21 | 4 | VIVO VENTURES VII, LLC By Vivo Ventures Fund VII, L.P. | DNAI | Common Stock | I | 17,0000 | 215 307 | 3 660 | 2 433 577 | ||||
| 2015-07-21 | 2015-07-21 | 4 | VIVO VENTURES VII, LLC By Vivo Ventures VII Affiliates Fund, L.P. | DNAI | Common Stock | I | 5,2150 | 2 324 | 12 | 2 218 270 | ||||
| 2015-07-21 | 2015-07-21 | 4 | VIVO VENTURES VII, LLC By Vivo Ventures Fund VII, L.P. | DNAI | Common Stock | I | 5,2150 | 106 647 | 556 | 2 215 946 | ||||
| 2015-07-21 | 2015-07-21 | 4 | VIVO VENTURES VII, LLC By Vivo Ventures VII Affiliates Fund, L.P. | DNAI | Common Stock | I | 44 991 | 2 109 299 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | VIVO VENTURES VII, LLC By Vivo Ventures Fund VII, L.P. | DNAI | Common Stock | I | 2 064 308 | 2 064 308 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | CHA ALBERT By Vivo Ventures VII Affiliates Fund, L.P. | DNAI | Series D Preferred Stock | I | −44 991 | 0 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | CHA ALBERT By Vivo Ventures Fund VII, L.P. | DNAI | Series D Preferred Stock | I | −2 064 308 | 0 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | CHA ALBERT By Vivo Ventures VII Affiliates Fund, L.P. | DNAI | Common Stock | I | 17,0000 | 4 693 | 80 | 2 438 270 | ||||
| 2015-07-21 | 2015-07-21 | 4 | CHA ALBERT By Vivo Ventures Fund VII, L.P. | DNAI | Common Stock | I | 17,0000 | 215 307 | 3 660 | 2 433 577 | ||||
| 2015-07-21 | 2015-07-21 | 4 | CHA ALBERT By Vivo Ventures VII Affiliates Fund, L.P. | DNAI | Common Stock | I | 5,2150 | 2 324 | 12 | 2 218 270 | ||||
| 2015-07-21 | 2015-07-21 | 4 | CHA ALBERT By Vivo Ventures Fund VII, L.P. | DNAI | Common Stock | I | 5,2150 | 106 647 | 556 | 2 215 946 | ||||
| 2015-07-21 | 2015-07-21 | 4 | CHA ALBERT By Vivo Ventures VII Affiliates Fund, L.P. | DNAI | Common Stock | I | 44 991 | 2 109 299 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | CHA ALBERT By Vivo Ventures Fund VII, L.P. | DNAI | Common Stock | I | 2 064 308 | 2 064 308 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | ORBIMED ADVISORS LLC See Footnotes | DNAI | Series D Preferred Stock | I | −1 725 790 | 0 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | ORBIMED ADVISORS LLC See Footnotes | DNAI | Common Stock | I | 17,0000 | 175 000 | 2 975 | 1 989 949 | ||||
| 2015-07-21 | 2015-07-21 | 4 | ORBIMED ADVISORS LLC See Footnotes | DNAI | Common Stock | I | 5,2150 | 89 159 | 465 | 1 814 949 | ||||
| 2015-07-21 | 2015-07-21 | 4 | ORBIMED ADVISORS LLC See Footnotes | DNAI | Common Stock | I | 1 725 790 | 1 725 790 | ||||||
| 2015-07-15 | 3 | You Angie | DNAI | Common Stock | D | 206 504 | ||||||||
| 2015-07-15 | 3 | You Angie | DNAI | Common Stock | D | 206 504 | ||||||||
| 2015-07-15 | 3 | Rodigueza Wendi | DNAI | Common Stock | D | 314 620 | ||||||||
| 2015-07-15 | 3 | Rodigueza Wendi | DNAI | Common Stock | D | 314 620 | ||||||||
| 2015-07-15 | 3 | Messmann Richard A | DNAI | Common Stock | D | 80 104 | ||||||||
| 2015-07-15 | 3 | Messmann Richard A | DNAI | Common Stock | D | 80 104 | ||||||||
| 2015-07-15 | 3 | Lovejoy Chandra D | DNAI | Common Stock | D | 26 844 | ||||||||
| 2015-07-15 | 3 | Lovejoy Chandra D | DNAI | Common Stock | D | 26 844 | ||||||||
| 2015-07-15 | 3 | Parfet Donald R By Apjohn Group, LLC | DNAI | Common Stock | I | 97 718 | ||||||||
| 2015-07-15 | 3 | Parfet Donald R By Apjohn Ventures Fund, LP | DNAI | Common Stock | I | 124 856 | ||||||||
| 2015-07-15 | 3 | Parfet Donald R By Apjohn Ventures Fund, LP | DNAI | Common Stock | I | 124 856 | ||||||||
| 2015-07-15 | 3 | Parfet Donald R By Apjohn Group, LLC | DNAI | Common Stock | I | 97 718 | ||||||||
| 2015-07-15 | 3 | Parfet Donald R | DNAI | Common Stock | D | 167 322 | ||||||||
| 2015-07-15 | 3 | Parfet Donald R | DNAI | Common Stock | D | 167 322 |
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)
